{"filing":{"accession_number":"0001178913-26-004334","cik":"0001498403","ticker":"BLRX","company_name":"BioLineRx Ltd.","form":"6-K","filing_date":"2026-08-31","report_date":"2026-08-31","primary_document":"zk2636031.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1498403/000117891326004334/zk2636031.htm"},"events":[{"id":30546,"run_id":27995,"accession_number":"0001178913-26-004334","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"BioLineRx entered into a securities purchase agreement on August 27, 2026, to sell 480,696 ADSs, pre-funded warrants to purchase 868,225 ADSs, and unregistered warrants to purchase 2,023,382 ADSs in a registered direct offering and concurrent private placement. The unregistered warrants component and the private placement structure are characteristic of a dilutive equity issuance. Aggregate gross proceeds are approximately $3.75 million, with the company intending to use net proceeds for R\u0026D and working capital.","company_name":"BioLineRx Ltd.","ticker":"BLRX","filing_date":"2026-08-31","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":33170,"accession_number":"0001178913-26-004334","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"BioLineRx entered into a securities purchase agreement on August 27, 2026, to sell 480,696 ADSs, pre-funded warrants to purchase 868,225 ADSs, and unregistered warrants to purchase 2,023,382 ADSs in a registered direct offering and concurrent private placement. The unregistered warrants component and the private placement structure are characteristic of a dilutive equity issuance. Aggregate gross proceeds are approximately $3.75 million, with the company intending to use net proceeds for R\u0026D and working capital.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-31T14:24:46.236781+00:00","company_name":"BioLineRx Ltd.","ticker":"BLRX","filing_date":"2026-08-31"}]}